Cases & Deals

North Coast invests in Cervilenz

Client(s) North Coast Angel Fund

Jones Day advised North Coast Angel Fund in its purchase of Series A Convertible Preferred Stock in a private placement by CerviLenz Inc., a manufacturer and marketer of a patented, FDA-cleared device to predict preterm birth risk in pregnant women.